Electro-thumbtack Needle Therapy for Chronic Neck Pain
Efficacy and Safety of Electro-thumbtack Needle Therapy for Patients With Chronic Neck Pain: a Randomized, Placebo-controlled Trial
1 other identifier
interventional
180
0 countries
N/A
Brief Summary
This prospective trial will be a single-center, participant-blinded, randomized controlled trial. It is reported in previous studies that both acupuncture and transcutaneous electrical nerve stimulation are effective in reducing neck pain comparing to placebo or exercise. Taking into account the convenience of electro-thumbtack needle therapy shown in clinical practice, this study aims to evaluate the efficacy and safety of electro-thumbtack needle therapy for alleviating chronic neck pain compared with sham electro-thumbtack needle therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2021
CompletedFirst Posted
Study publicly available on registry
July 28, 2021
CompletedStudy Start
First participant enrolled
April 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMarch 31, 2022
March 1, 2022
1.7 years
July 18, 2021
March 24, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of participants with an at least 50% decrease in NRS-NP from baseline.
Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)
week 4
Secondary Outcomes (8)
Change of NRS-NP from baseline.
week 4, 16, 28
Proportion of participants with an at least 50% decrease in NRS-NP from baseline.
week 16, 28
Proportion of participants with an at least 30% decrease in NRS-NP from baseline.
week 4, 16, 28
Change of NPQ from baseline.
week 4, 16, 28
Proportion of participants with an at least 25% decrease in NPQ from baseline and a "better" or "much better" for global effectiveness rating.
week 4, 16, 28
- +3 more secondary outcomes
Other Outcomes (5)
Self-expectation assessment.
baseline
Preference of ETN assessment.
baseline
Blinding assessment.
week 4
- +2 more other outcomes
Study Arms (2)
Electro-thumbtack Needle Therapy (ETN) group
EXPERIMENTALElectro-thumbtack needles (0.25×2 mm) will be inserted into acupoints of Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) after sterilization. Then apply the gel electrodes and stimulation devices, turn on the device to produce a proper electric stimulation that the participant can tolerate.
Sham Electro-thumbtack Needle Therapy (ETN) group
SHAM COMPARATORSham electro-thumbtack needles (0.25×0.2 mm) which are specially produced have blunt tips instead of sharp needle tip. They will be taped on acupoints of Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) after sterilization. Then apply the gel electrodes and stimulation devices, produce a minimal level of electric stimulation for 30 seconds before turning off the device.
Interventions
Each treatment session starts with sterilizing acupoints. Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) have been selected in accordance with the principle of acupuncture prescription making and the consensus of experts on treating neck pain. Electro-thumbtack needles (0.25×2 mm) will be held by the acupuncturist between thumb and forefinger, vertically inserted into skin instantly and taped well on skin. Then assemble the gel electrodes to the surface of the conductive adhesive tape, also assemble the portable stimulation devices, adjust the current intensity from level 1 to a proper level that the participant can tolerate. Participants will receive three 30-min treatment sessions per week every other day for 4 consecutive weeks.
Each treatment session starts with sterilizing acupoints. Sham electro-thumbtack needles (0.25×0.2 mm) will be held by the acupuncturist between thumb and forefinger, taped well on skin without penetration. The adhesive tape of needles are also produced with conductive material, after assembling the gel electrodes and the portable stimulation devices, adjust the current intensity to level 1 for a minimal stimulus which will last for only 30 seconds. By this time the acupuncturist will turn the device off to cut the current. Participants will receive three 30-min treatment sessions per week every other day for 4 consecutive weeks.
Eligibility Criteria
You may qualify if:
- Diagnosed with neck pain with headaches or neck pain with movement coordination impairments according to the Orthopaedic Section of the American Physical Therapy Association (APTA);
- Aaged 18-65 years;
- History of neck pain for at least 3 months;
- A score of ≥4 in Numerical Rating Scale for neck pain (NRS-NP) assessing the average neck pain intensity over last 7 days until the day of recruitment.
You may not qualify if:
- Diagnosed with neck pain with mobility deficits or neck pain with radiating pain according to the Orthopaedic Section, APTA;
- Known specific reason leading to neck pain such as tumor, immune disease, endocrine and metabolic disorders, neurological abnormalities, cervical vertebra fracture, cervical dislocation;
- Acute neck pain or neck pain with radiating pain or upper limb symptoms;
- Neck pain with sensory or motor disturbance;
- Prior cervical spine surgery or congenital abnormalities;
- Experiencing medical dispute litigation;
- Have received acupuncture in last 30 days;
- In need of analgesic, muscle relaxant, hormones, or bearing greater pain from another area;
- Allergic to metal or adhesive tape, or carrying cardiac pacemaker, or skin damaged at selected acupoints;
- Disable to communicate or critically ill;
- Drug or alcohol dependent;
- Currently or planning to be pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shi Hangyulead
Related Publications (1)
Shi H, Wang X, Yan Y, Zhu L, Chen Y, Gao S, Liu Z. Efficacy and Safety of Electro-Thumbtack Needle Therapy for Patients With Chronic Neck Pain: Protocol for a Randomized, Sham-Controlled Trial. Front Med (Lausanne). 2022 Apr 29;9:872362. doi: 10.3389/fmed.2022.872362. eCollection 2022.
PMID: 35572961DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hangyu Shi
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 18, 2021
First Posted
July 28, 2021
Study Start
April 3, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
March 31, 2022
Record last verified: 2022-03